Is the rise in parathyroid hormone a normal physiological adaptation during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Parathyroid Hormone Changes in Normal Pregnancy

Parathyroid hormone (PTH) levels typically decrease or remain low-normal during pregnancy, particularly in the first and second trimesters, rather than increasing as a normal maternal adaptation. 1, 2

Normal Physiologic Pattern

The evidence consistently demonstrates that intact PTH levels follow a specific pattern during pregnancy:

  • First and second trimesters: Serum intact PTH concentrations are significantly decreased compared to non-pregnant women 1, 2
  • Third trimester: PTH levels may normalize but generally remain within or below the normal non-pregnant range 2
  • Mean PTH levels: Studies using modern intact PTH assays show pregnant women have mean PTH of 14.4 ± 6.3 ng/L compared to 24.8 ± 9.0 ng/L in non-pregnant women (P < 0.001) 1

Why the Confusion Exists

Older studies using traditional radioimmunoassays (RIAs) incorrectly suggested "physiological hyperparathyroidism of pregnancy" because these assays detected inactive PTH fragments rather than biologically active intact PTH. 1 Modern immunoradiometric assays for intact PTH have definitively shown this concept to be incorrect.

Mechanism of PTH Suppression

The decrease in PTH during pregnancy appears to be a secondary response to changes in calcium homeostasis:

  • Ionized calcium levels decrease significantly between 21-25 weeks' gestation (from 3.81 to 3.63 mg/dl, P < 0.01) 3
  • Despite this decrease in ionized calcium, PTH remains suppressed or only modestly elevated, suggesting other factors (likely placental calcium transport and increased calcitriol production) maintain calcium homeostasis 3
  • Total serum calcium is lower in normal pregnancy, but ionized calcium remains within normal limits 4

Clinical Implications

When PTH is elevated during pregnancy, this is NOT a normal adaptation and warrants investigation for:

  • Primary hyperparathyroidism: The most common pathologic cause (80% due to parathyroid adenoma), which increases maternal and fetal morbidity 4, 5
  • Vitamin D deficiency: Should be corrected first, as this is the most common cause of secondary PTH elevation 6
  • Malabsorption states: Particularly in women with prior bariatric surgery 7, 6

Monitoring Recommendations

In high-risk populations (e.g., post-bariatric surgery), PTH should be monitored alongside calcium, phosphate, magnesium, and 25-hydroxyvitamin D every trimester or every six months. 7, 6 The goal is to maintain PTH within the normal reference range through adequate vitamin D (≥50 nmol/L) and calcium supplementation (1,200-1,500 mg daily). 6

Key Pitfall to Avoid

Do not dismiss elevated PTH as a "normal pregnancy change." Any elevation of PTH during pregnancy should prompt evaluation for underlying pathology, particularly when serum calcium is elevated above 2.75 mmol/L, as this requires urgent intervention to prevent maternal complications (pancreatitis, hypercalcemic crisis) and fetal complications (prematurity, neonatal hypocalcemia). 5

References

Research

[Changes in serum parathyroid hormone levels during pregnancy].

Rinsho byori. The Japanese journal of clinical pathology, 1989

Research

Parathyroid disorders of pregnancy.

Seminars in perinatology, 1998

Research

Primary hyperparathyroidism during pregnancy.

Archives of gynecology and obstetrics, 2015

Guideline

Management of Parathyroid Hormone (PTH) in Pregnancy After Bariatric Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Monitoring Calcium and PTH in Pregnant Women After Bariatric Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.